Anti-Human CD221 Recombinant Antibody(Robatumumab)
-
产品编号
YR1196
-
别名
科研级 Robatumumab ( 罗妥木单抗 ), Anti-CD221 Recombinant Antibody, Research Grade Robatumumab
-
规格
- 1mg
- 5mg
Alias | 科研级 Robatumumab ( 罗妥木单抗 ), Anti-CD221 Recombinant Antibody, Research Grade Robatumumab |
Catalog Number | YR1196 |
Molecular Name | Robatumumab |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | IgG1 Kappa |
Formulation | PBS, pH7.5 |
Background | Robatumumab (proposed INN, also known as SCH 717454 and MK-7454) is a monoclonal antibody and an antineoplastic by Merck and Schering-Plough. It binds to CD221, the insulin-like growth factor 1 receptor. Phase 2 clinical trials in patients with colorectal cancer, osteosarcoma and Ewing's sarcoma are complete. Merck has since discontinued development. |
CAS Number | 934235-44-6 |
Application | FuncS, IF, Neut, ELISA, FCM, IP |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Target | CD221[Homo sapiens] |